Clinical StudyRacial disparities in medicaid patients after brain tumor surgery
Introduction
Since the Institute of Medicine’s “Crossing the Quality Chasm” was published in 2001, equitable delivery has remained a key aspect in defining quality healthcare.1 However, the presence of healthcare-related disparities between different racial groups within the USA remains an ongoing, widespread, and well-documented societal and health policy issue.2, 3 Disparate access and outcomes after treatment of numerous acute and chronic medical conditions, inclusive of cancer, have been shown consistently over the past several decades, even after accounting for differences in geographic location, patient educational level, and other potential determinants of health and behavior.4, 5
With the publication of “Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care” by the Institute of Medicine in 2003, the prevalence of such disparities began to reach a higher level of attention within the realm of health services research.6 As a result, projects within the general medical literature focusing upon disparities grew over the subsequent decade, with newer reports suggesting patient mistrust as well as provider bias may have both played roles in the disparate outcomes observed among otherwise similar groups treated equally.7, 8
Until recently, relatively few studies have evaluated disparities in short-term and long-term outcomes within the subspeciality of neurosurgery.9, 10, 11, 12, 13 The few reports that have attempted to explore racial disparities in post-operative brain tumor patient outcomes have reported that patients of African-American ethnicity diagnosed with malignant brain tumors have shorter survival,9, 10 more severe disease at presentation,13 and are treated more often at low-volume hospitals11, 12 compared to their Caucasian counterparts.
However, most of these studies attempt to control for important determinants of health including socioeconomic status using suboptimal regional surrogates, such as median income within the patient’s postal code or county of residence. In an attempt to mitigate potentially confounding variables such as socioeconomic status, we utilized the Medicaid portion of the MarketScan database to evaluate racial disparities in a homogeneous, low-income population of patients undergoing craniotomy for tumor resection.
Section snippets
Database
Thomson Reuter’s MarketScan database from 2000 to 2009 was used for analysis. The MarketScan database is a collection of six different data files, including the: (i) Commercial Claims and Encounters file, (ii) Medicare Supplemental and Coordination of Benefits (COB) file, (iii) Benefit Plan Design file, (iv) Health and Productivity Management file, (v) Medicaid file, and (vi) Lab file. For the current project, we used only the Medicaid database, which is formed by health-care use information
Results
Our study identified 2321 patients in the Medicaid database who underwent craniotomy for brain tumor between 2000 and 2009. The mean age of patients was 49 years of age and 57.8% were women. Patients of African-American ethnicity comprised 26.3% (n = 611) and only 26.6% of patients were treated at high-volume hospitals. Charlson comorbidity index was >3 in 43.8% of patients. Overall inpatient mortality was 2.0% with a mean LOS of 9 days and mean total charges of US$42,422. An adverse discharge
Discussion
In this study, we demonstrate several significant racial disparities in both inpatient and short-term post-operative outcomes after craniotomy for resection of brain tumors. Among all tumor types, we found in multivariate analyses that African-American patients had significantly higher 30-day complication rates, significantly longer LOS, and accrued significantly greater healthcare related charges. Post-operatively African-American patients with meningioma seemingly had the worst disparities.
Conflict of interest/disclosures
The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.
Acknowledgement
The authors wish to thank Sherry Brandon for her expert help with copyediting, referencing and administrative support provided on this project.
References (26)
- et al.
Understanding racial disparities in cancer treatment and outcomes
J Am Coll Surg
(2010) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
J Clin Epidemiol
(1992) - et al.
Insurance status and inequalities in outcomes after neurosurgery
World Neurosurg
(2011) - et al.
Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment
World J Surg Oncol
(2008) - Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century....
- et al.
The quality of health care delivered to adults in the United States
N Engl J Med
(2003) - et al.
Who is at greatest risk for receiving poor-quality health care?
N Engl J Med
(2006) - et al.
Treatment disparities following the diagnosis of an astrocytoma
J Neurooncol
(2011)
Perceptions of breast cancer treatment among African-American women and men: implications for interventions
J Gen Intern Med
Association of unconscious race and social class bias with vignette-based clinical assessments by medical students
JAMA
Racial differences in survival after diagnosis with primary malignant brain tumor
Cancer
Cited by (52)
High-Value Care Outcomes of Meningiomas
2023, Neurosurgery Clinics of North AmericaSystematic Review of Racial, Socioeconomic, and Insurance Status Disparities in Neurosurgical Care for Intracranial Tumors
2022, World NeurosurgeryCitation Excerpt :In this discussion, we address the most salient findings in our study and discuss potential root causes of these disparities to help guide further research and policy. Most studies reported that minority patients and specifically African American5,10,11,14,17,25,29,31,36-38 patients had the highest rates of mortality, decreased postoperative survival, increased complications after surgery, increased rates of readmission, and worst access to high-volume centers across a wide variety of intracranial tumor diseases. Although mortality was well studied, studies examining LOS, complications, discharge disposition, readmission, and reoperation were fewer.
The Effect of Race on Short-Term Pituitary Tumor Outcomes
2020, World Neurosurgery
- †
These authors contributed equally to the manuscript.